CoChat

Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study

Open access
Ewertz, M, Mellemkjaer, L, Poulsen, A H, Friis, S, Sørensen, H T, Pedersen, L, McLaughlin, J K, Olsen, J H · 2005 · British Journal of Cancer
Cited by 92

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Numerous studies and meta-analyses have shown that hormone replacement therapy (HRT) for menopausal symptoms increases the risk of developing breast cancer, estimated to be 2.3% for each year of use. The influence of different oestrogen-progestin regimens has still not been fully evaluated. Using longitudinal data from the population-based prescription database of the county of North Jutland, Denmark, and the Danish Cancer Registry, we examined the risk of developing breast cancer in relation to HRT in a cohort of 78,380 women aged 40-67 years from 1989 to 2002. A total of 1462 cases of breast cancer were identified during a mean follow-up of 10 years. Use of HRT did not increase the risk of breast cancer in women aged 40-49 years. Restricting the cohort to 48,812 women aged 50 years or more at entry, of whom 15 631 were HRT users, we found an increased risk associated with current use of HRT (relative risk 1.61, 95% confidence interval 1.38-1.88). The risk increased with increasing duration of use and decreased with time since last HRT prescription, reaching unity after 5 years. No material risk difference was observed among the various HRT-regimens. This population-based cohort study provides further confirmation that HRT increases the risk of developing breast cancer in women aged 50 years or more.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6602472

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 14

  1. Capellá D (1993) Descriptive tools and analysis. In Drug Utilization Studies: Methods and Uses, European Series No. 45 Dukes MNG (ed) pp 55–78. Copenhagen: WHO Regional Publications
  2. Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 350: 1047–1059 · DOI · Paper page
  3. Danø H, Andersen O, Ewertz M, Petersen JH, Lynge E (2003) Socioeconomic status and breast cancer in Denmark. Int J Epidemiol 32: 218–224 · doi:10.1093/ije/dyg049
  4. Gaist D, Sørensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44: 445–448
  5. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Mar JE, Hennekens CH, Rosner B, Speizer FE, Willett WC (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278: 1448–1449 · DOI · Paper page
  6. Hulley SB, Grady D (2004) The WHI estrogen-alone trial – do things look any better? JAMA 291: 1769–1771 · DOI · Paper page
  7. Løkkegaard E, Johnsen SP, Heitman BL, Stahlberg C, Pedersen AT, Obel EB, Hundrup YA, Hallas J, Sørensen HT (2004) The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand 83: 476–481 · DOI
  8. Magnusson C, Baron JA, Correia N, Bergstrom R, Adami H-O, Persson I (1999) Breast cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 81: 339–344 · doi:10.1002/(sici)1097-0215(19990505)81:3<339::aid-ijc5>3.0.co;2-6
  9. Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419–427 · DOI · Paper page
  10. Olesen AV, Johnsen SP, Mortensen JT, Bøggild H, Olsen J, Sørensen HT (2004) Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women. Acta Obstet Scand (in press) · doi:10.1111/j.0001-6349.2005.00526.x
  11. Stahlberg C, Pedersen AT, Lynge E, Andersen ZJ, Keiding N, Hundrup YA, Obel EB, Ottensen B (2004) Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe. Int J Cancer 109: 721–727 · DOI · Paper page
  12. Storm HH, Michelsen EV, Clemmensen I, Pihl J (1997) The Danish Cancer Registry – history, content, quality and use. Dan Med Bull 44: 549–553
  13. Tjønneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewertz M, Mellemkjær L (2004) Hormone replacement therapy in relation to breast carcinoma incidence rate ratios. A prospective Danish cohort study. Cancer 100: 2328–2337 · DOI
  14. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women, principal results from the Women's health initiative randomized controlled trial. JAMA 288: 321–333 · DOI · Paper page

Cited by

See all 92

Metadata

Authors
Ewertz, M., Mellemkjaer, L., Poulsen, A. H., Friis, S., Sørensen, H. T., Pedersen, L., McLaughlin, J. K., & Olsen, J. H.
Venue
British Journal of Cancer
Published
2005-03-22
Volume
92
Issue
7
Pages
1293-1297
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W1991613054
Cited by
92
References
1
FWCI
3.28
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. https://app.cochat.ai/papers/10.1038/sj.bjc.6602472
The paper
Ewertz, M., Mellemkjaer, L., Poulsen, A. H., Friis, S., Sørensen, H. T., Pedersen, L., McLaughlin, J. K., & Olsen, J. H. (2005). Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6602472

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.